Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The journey from laboratory synthesis to clinical application for pharmaceuticals is often complex, relying heavily on the availability and quality of key intermediates. Within the realm of oncology, the targeted therapy drug Cabozantinib has shown significant promise in treating various types of cancer. Central to its production is the vital intermediate, 4-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline, identified by CAS 190728-25-7. This article highlights its indispensable role in the supply chain of this critical medication.
4-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline, often referred to as a quinoline derivative, provides the structural framework necessary for Cabozantinib's efficacy. Its meticulous synthesis, ensuring high purity levels (often ≥98% HPLC), is a testament to the precision required in pharmaceutical manufacturing. The reliable production and supply of this intermediate are crucial for pharmaceutical companies aiming to meet the demand for Cabozantinib, making the understanding of its 4-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline synthesis a priority for manufacturers like NINGBO INNO PHARMCHEM CO.,LTD.
As a Cabozantinib intermediate, this compound contributes to the drug's ability to inhibit multiple receptor tyrosine kinases, which are implicated in tumor growth, metastasis, and angiogenesis. The consistent availability of this pharmaceutical intermediate CAS 190728-25-7 ensures that research and manufacturing efforts can proceed without interruption, ultimately benefiting patients who rely on Cabozantinib for their treatment. NINGBO INNO PHARMCHEM CO.,LTD.'s dedication to providing this material supports the ongoing fight against cancer.
The demand for such specialized compounds also drives innovation in chemical synthesis. Companies focusing on organic intermediate for drug development continually seek to optimize production methods, reduce costs, and enhance environmental sustainability. Exploring different buy options and supplier networks for this chemical intermediate is a strategic imperative for many pharmaceutical firms.
In essence, 4-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline is more than just a chemical; it is a critical link in the chain that delivers advanced cancer therapies to patients. Its availability, quality, and efficient synthesis directly impact the accessibility of life-changing treatments, underscoring its profound importance in the pharmaceutical industry.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
